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a b s t r a c t
The ﬁrst step of herpesviruses virion assembly occurs in the nucleus. However, the exact site where
nucleocapsids are assembled, where the genome and the inner tegument are acquired, remains
controversial. We created a recombinant VZV expressing ORF23 (homologous to HSV-1 VP26) fused to
the eGFP and dually ﬂuorescent viruses with a tegument protein additionally fused to a red tag (ORF9,
ORF21 and ORF22 corresponding to HSV-1 UL49, UL37 and UL36). We identiﬁed nuclear dense structures
containing the major capsid protein, the scaffold protein and maturing protease, as well as ORF21 and
ORF22. Correlative microscopy demonstrated that the structures correspond to capsid aggregates and
time-lapse video imaging showed that they appear prior to the accumulation of cytoplasmic capsids,
presumably undergoing the secondary egress, and are highly dynamic. Our observations suggest that
these structures might represent a nuclear area important for capsid assembly and/or maturation before
the budding at the inner nuclear membrane.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Varicella-zoster virus (VZV) is a human pathogen belonging to the
alphaherpesviruses subfamily, whose most characterized member is
the human Herpes Simplex Virus-1 (HSV-1). VZV causes varicella as
primary infection and zoster when the virus eventually reactivates
(Arvin, 1996).
The ﬁrst steps of herpesviruses virion assembly occur in the
nucleus where the replicated DNA must be embedded into the
preformed capsids. It is quite well established that the replication
starts at speciﬁc spots that increase over time, in number and
mainly in size, until they ﬁnally fuse to give rise to what has been
called the “replication compartment” (RC) (de Bruyn Kops and
Knipe, 1994; Kobiler et al., 2011; Quinlan et al., 1984).
HSV-1 capsid assembly is well documented (for review see
Cardone et al., 2012; Homa and Brown, 1997). In the nucleus, the
subunits are assembled into procapsids around a protein scaffold
containing the products of two overlapping in-frame genes, UL26
(VZV ORF33) and UL26.5 (VZV ORF33.5) (Thomsen et al., 1995).
The polypeptide encoded by UL26 (VP24þpre-VP21) shares its
C-terminal part with the one coded by UL26.5 (pre-VP22a), but
possesses an extra N-terminal part consisting of a protease motif
and a linker peptide. Once the procapsid is formed, the protease
motif (VP24) becomes activated and frees itself through an
autocatalytic cleavage. The activated VP24 gives then rise to
mature VP21 and VP22a via another proteolytic cleavage at the
C-terminal end of both precursors (Newcomb et al., 2000).
Procapsids are thought to be transient intermediates at the origin
of the three types of capsid that are generally found in the nucleus
of an infected cell. Capsids A, B and C share the outer shell
composed of capsomers of VP5 (homologous to VZV ORF40) linked
via a triplex containing two molecules of VP23 (VZV ORF41) and
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/yviro
Virology
http://dx.doi.org/10.1016/j.virol.2014.02.023
0042-6822 & 2014 Elsevier Inc. All rights reserved.
n Corresponding author. Mailing address: Laboratory of Virology and Immunol-
ogy, University of Liege, Avenue de l'Hopital 1, GIGA-R, B34 (þ5), B-4000 Liege,
Belgium. Tel.: þ32 4 366 24 45; fax: þ32 4 366 41 98.
E-mail address: csadzot@ulg.ac.be (C. Sadzot-Delvaux).
1 Present address: Coris BioConcept, Science Park CREALYS, Rue Jean Sonet 4A,
B-5032 Gembloux, Belgium.
2 Present address: Institute for Medical Immunology, ULB, Rue Adrienne
Bolland 8, B-6041 Gosselies, Belgium.
3 Present address: AIDS Reference Laboratory, CHU, ULG, B23, Avenue de
l'hopital 1, B-4000 Liege, Belgium.
Virology 454-455 (2014) 311–327
one of VP19C (VZV ORF20) and decorated by the small capsid
protein VP26 (VZV ORF23) (Spencer et al., 1998). The inside of the
capsid is either empty (type A) when the expulsion/degradation
of the scaffold is not followed by DNA insertion, ﬁlled with DNA
(type C) or ﬁlled with truncated VP22a (type B), which is a scaffold
remnant resulting from cleavage by the viral protease during the
encapsidation process (Newcomb et al., 1996; Salmon et al., 1998)
(for review see Cardone et al., 2012).
The exact place where the replicated DNA is cleaved and
encapsidated and where the capsid acquires its inner and outer
tegument is still a matter of debate (de Bruyn Kops et al., 1998;
Taus et al., 1998). Immunoﬂuorescence using speciﬁc antibodies
and, more recently, the fusion of viral genes with genes coding for
ﬂuorescent proteins coupled with confocal microscopy have
signiﬁcantly helped to decipher the complex virion formation
process from the nuclear steps to the ﬁnal egress at the cell
surface (de Oliveira et al., 2008; Luxton et al., 2005; Smith et al.,
2004; Sugimoto et al., 2008). Early in infection, capsid proteins
are frequently found in the replication compartment, whereas
later time points are characterized by the appearance of very
dense structures localized at the periphery of the RC. These
structures comprise both mature and immature capsid proteins
as well as some tegument proteins and have been called “assem-
blons” (Ward et al., 1996). Their potential role in the infection
process is controversial, as they could either be a functional
compartment highly specialized in nucleocapsid formation or a
depot of dead-end products resulting from a protein excess
(Abaitua and O'Hare, 2008; Hutchinson et al., 2002; Lee et al.,
2006; Markovitz and Roizman, 2000; Ward et al., 1996).
We know little about VZV nucleocapsid formation, but, based
on HSV-1 homology, one should expect a similar process, even
though some peculiar features, like the nuclear import of capsid
subunits, have already been described (Chaudhuri et al., 2008).
In this study, we created a recombinant VZV whose capsid protein
ORF23 (homolog to VP26) is fused to the green ﬂuorescent protein, as
well as the ﬁrst described VZV dually ﬂuorescent viruses where a
tegument protein (ORF9, ORF21 or ORF22, respectively) is additionally
fused to a red ﬂuorescent protein. With these viruses, we showed that
(i) nuclear structures located at the periphery of the RC are formed
during VZV infection; (ii) they appear in all cell types around 8–12 h
post-infection, as soon as the RC starts to form; (iii) they contain
capsid/procapsid proteins, some but not all tegument proteins,
whereas they do not contain proteins associated with DNA replication
and encapsidation; (iv) they are not only mainly constituted of fully
assembled capsids of the three types, but also many procapsids, as
well as a few partial capsids; and (v) they are highly dynamic. We
believe that the observed structures might represent a place where
capsids are preferentially assembled and/or accumulated after or
during their formation, and before their egress towards the cytoplasm.
Results
Construction of an eGFP-ORF23-tagged VZV.
In order to study the nuclear steps of VZV virion assembly, we
generated a virus whose minor capsid protein ORF23 (HSV-1 VP26
homolog) is fused to the green ﬂuorescent protein (eGFP). Homo-
logous recombination in Escherichia coli was used to modify a BAC
containing the entire pOka genome of VZV. In two separate experi-
ments, we inserted the eGFP coding sequence either upstream or
downstream of the orf23 gene (Fig. 1A). The two BACs were trans-
fected in MeWo cells, which were passaged near conﬂuence until
typical infection foci appeared. In three successive experiments,
transfection of the BAC ORF23-eGFP failed to give rise to infection
foci, even four weeks after transfection, whereas transfection of the
BAC eGFP-ORF23 led to a productive infection. The growth property of
the ﬂuorescently labeled virus was compared with a pOka strain
obtained after the transfection of the unmodiﬁed BAC-VZV. Even
though the recombinant virus is viable and infectious, the expression
of a ﬂuorescently tagged ORF23 alters viral growth (Fig. 1B). The
expression of the eGFP-fusion proteinwas veriﬁed by western-blotting
on total cell extracts of infected MeWo cells with an antibody against
GFP (Fig. 1C). The fusion protein is detected as a doublet, slightly
higher than expected from the predicted molecular weight (51 kDa).
This is consistent with previously published results suggesting
that ORF23 might present phosphorylation-dependent isoforms
(Chaudhuri et al., 2008).
Intense nuclear ﬂuorescent spots appear in VZV-infected cells
Living MeWo cells asynchronously infected with eGFP-VZV display
speciﬁc ﬂuorescence patterns characterizing their stage of infection.
At early stages, infected cells present arrays of incoming capsids
docked at the nuclear membrane (Fig. 2A, cell 1). At the beginning of
the late phase of gene expression, ORF23 starts to be produced, which
is characterized by a diffuse eGFP signal both in the cytoplasm and the
nucleus (Fig. 2A, cell 2). At later stages, the assembly of progeny
virions initiates and bright dots corresponding to single capsids show
up in the nucleus (Fig. 2A, cell 3), after which very intense larger
nuclear ﬂuorescent spots resembling HSV-1 assemblons begin to
appear (Fig. 2A, cell 4).
Because HSV-1 assemblons form only in certain cell types and
at very late time points (Ward et al., 1996), which casts doubt on
their potential role in capsid assembly, we ﬁrst wanted to evaluate
the presence of such nuclear structures in various cell types.
Human primary foreskin ﬁbroblasts (HFF) were infected via a
20 min cell contact with eGFP-ORF23-infected MeWo cells, fol-
lowed by extensive washing, and a coverslip was ﬁxed every hour
in a 24 h time frame. The cells were immunostained against beta-
tubulin and analyzed by confocal microscopy. Selected time points
are presented in Fig. 2B. Incoming capsids docked at the nuclear
envelope were observed 3 h p.i. (this stage corresponds to cell 1 in
Fig. 2A), but the green diffused ﬂuorescence resulting from de novo
ORF23 expression only became detectable at around 6 h p.i. (this
stage correspond to cell 2 in Fig. 2A). At 8 h p.i., newly assembled
capsids appeared throughout the nucleus (like cell 3 in Fig. 2A),
sometimes in tiny aggregates. Brighter and larger ﬂuorescence
dots, similar to those seen in MeWo cells (cell 4, Fig. 2A), were
present from 12 h p.i. and grew in size as the infection progressed
(Fig. 2B). In a parallel experiment, time-lapse video imaging was
performed and conﬁrmed the successive pattern (1–4) of the
green ﬂuorescence as the infection progressed (Movie S1). The
brightness of the eGFP enables the detection of single capsids
inside infected cells and the analysis of several movies showed
that it takes about 3 h from the emergence of the diffused eGFP
signal until newly formed capsids show up in the nucleus (a 2 h
30 min time frame separates stages 2 and 3 in Movie S1), and only
one more hour until the larger ﬂuorescent spots begin to form
(Fig. 2C compare t0þ30' and t0þ75' or t0þ90'). We noticed that
the larger ﬂuorescent spots actually appeared before the massive
accumulation of capsids in the cytoplasm, where secondary
envelopment occurs (Movie S1, cell on the left, Fig. 2C compare
t0þ75' with t0þ4 h 15 or t0þ5 h 45 and Movie S2, arrows). Such
nuclear dense ﬂuorescent structures also formed in human pri-
mary embryonic lung ﬁbroblasts (MRC5) and human keratinocytes
immortalized via permanent TERT expression (N/TERT-1) (Fig. 2D).
The latter cell line had been shown to maintain most of the
characteristics of primary keratinocytes and constituted a model
closer to the preferential natural host of the virus. One should also
note that similar nuclear dense structures also appeared both with
a virus generated in our lab and expressing ORF23 fused to the
M. Lebrun et al. / Virology 454-455 (2014) 311–327312
tagRFP-T, which is a true monomeric red ﬂuorescent protein (Fig.
S1A), and in wild-type-VZV-infected cells labeled with an anti-
ORF23 antibody (Fig. S1B). The fact that these structures appear
very early, before the massive accumulation of capsids in cyto-
plasmic areas, and their presence in all tested cell lines contrasts
with the characteristics described for HSV-1 assemblons, led to our
decision to investigate whether they share other features.
VZV induced nuclear dense structures are located at the periphery of
the RC and contain the major capsid protein, the procapsid scaffold
protein but not the DNA terminase subunit 1
We ﬁrst wondered whether other viral proteins implicated in
the different nuclear steps of virion formation were present in
these discrete nuclear compartments.
MRC5 cells were infected by a 20 min contact with eGFP-ORF23
VZV MeWo cells followed by extensive washing. Coverslips were
then ﬁxed at 8, 12, 16, 24 and 36 h p.i. and immunostained for
ORF29 (the single-strand DNA binding protein, homologous to
HSV-1 ICP8), ORF40 (major capsid protein, homologous to HSV-1
VP5), uncleaved ORF33/33.5 (procapsid scaffold protein, homo-
logous to pre-VP21/VP24 and pre-VP22a) and ORF45/42 (DNA
packaging terminase, subunit 1, homologous to UL15). Selected
time points are presented in Figs. 3 and 4. The expression of ORF29
allowed us to delineate the RC (Fig. 3, dashed line) which started
Fig. 1. Creation of an eGFP-ORF23 VZV. (A) Schematic representation of the BAC-VZV ΔGFP and of the genomic region of the two BACs where ORF23 has been fused to eGFP.
AmpR, Ampicillin resistance gene; 60, 61 and 23, position of the corresponding ORF within the BAC. (B) Growth curve of the eGFP-ORF23 VZV compared to the pOka parental
strain (WT). At day 0, four 25 cm2 ﬂasks were prepared by mixing 3  106 uninfected MeWo cells with 200 VZV infected cells. At the indicated periods of time, the number
of plaque forming units (PFU) was assessed as described in the Materials and methods section. Means of a representative experiment out of three are depicted; error bars
represent the standard deviation. (C) Western-blotting on total cell extract of MeWo infected with eGFP-ORF23 VZV with an antibody against GFP (expected size of the fusion
protein: 51 kDa).
Movie S1. Live imaging of HFF cells infected with eGFP-ORF23. HFF cells were
seeded on 35-mm glass bottom dish and infected with eGFP-ORF23 VZV via a 20-
min cell contact with MeWo cells. 12h post infection, images were recorded every
15 min over a 13 h time frame using a confocal microscope equipped with a
chamber controlling the temperature, as well as the humidity and CO2 level.
Confocal microscope images were captured with a 60 oil-objective. A video clip is
available online. Supplementary material related to this article can be found online
at doi:10.1016/j.virol.2014.02.023.
Movie S2. The nuclear dense structures appear prior the massive accumulation of
newly formed capsids within the cytoplasm. HFF were infected via cell contact with
eGFP-ORF23 MeWo cells. 12h post infection, ﬁelds where the cells presented a
diffuse cytoplasmic and nuclear signal and few nuclear dots corresponding to
individual capsids were selected. Images were recorded every 10 min over a 14 h
time frame using a confocal microscope equipped with a chamber controlling the
temperature, as well as the humidity and CO2 level. Confocal microscope images
were captured with a 60 oil-objective. The white arrows point to the nuclear
intense ﬂuorescent spots; cyan arrows show the accumulation of capsids within
the cytoplasm. A video clip is available online. Supplementary material related to
this article can be found online at doi:10.1016/j.virol.2014.02.023.
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Fig. 2. Nuclear dense structures form in eGFP-ORF23 VZV infected cells. (A) Live visualization of MeWo cells infected for 24 h with eGFP-ORF23 VZV. Nuclei were stained
with Hoechst 33342 and confocal microscope images were captured with a 63 oil-objective. Numbering represents gradual stages of infection. (B) Human primary foreskin
ﬁbroblasts (HFF) were infected with eGFP-ORF23 VZV via a 20-minute contact with MeWo cells followed by extensive washing. HFF were ﬁxed at indicated times p.i. and
immunostained against beta-tubulin (Alexa568 secondary antibody). (C) Selected frames of a time-lapse experiment of human primary foreskin ﬁbroblasts (HFF) infected
with eGFP-ORF23 VZV; white arrows point to the onset of the ﬁrst newly assembled capsids (1), followed by the emergence of nuclear dense structures (2) and the
apparition of capsids in cytoplasmic areas (3). (D) Human primary embryonic lung ﬁbroblasts (MRC5) and human normal keratinocytes immortalized by permanent TERT
expression (N/TERT-1) infected with eGFP-ORF23 were ﬁxed 24 h p.i. and nuclei counterstained with Hoechst 33342. Confocal microscope images were captured with a 63
oil-objective.
Fig. 3. The nuclear dense structures contain the major capsid protein and partially overlap with ORF29. MRC5 infected with eGFP-ORF23 VZV were ﬁxed at indicated times
p.i. and immunostained with both mouse anti-ORF40 and rabbit anti-ORF29 primary antibodies. Alexa568-anti-rabbit and Alexa633-anti-mouse were used as secondary
antibodies. Confocal microscope images were captured with a 63 oil-objective. The ORF29 staining was used to draw the dashed line representing the RC, which was then
reported on the eGFP picture. Cyan arrows show partial overlapping between eGFP-ORF23 and ORF29 signals. White arrows point to structures where ORF40 co-localizes
with eGFP-ORF23.
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Fig. 4. The procapsid scaffold protein but not the DNA terminase subunit 1 is present in the nuclear dense structures. MRC5 infected with eGFP-ORF23 VZV were ﬁxed at the
indicated times p.i. and immunostained with an anti-ORF33/33.5 (scaffold protein and maturing protease) (A) or an anti-ORF45/42 (DNA terminase subunit 1) (B) primary
antibody (Alexa568 secondary antibody in both cases). Confocal microscope images were captured with a 63 oil-objective. White arrows point to co-localization.
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to form around 8 h p.i. at several spots that enlarged and fused in a
single large area around 24 h p.i. The ORF29 labeling partially
overlapped the eGFP signal (Fig. 3, cyan arrows) but the co-
localization area remained rather discrete and did not grow with
the infection. This suggests that, if there is any, viral DNA
replication can only occur in a very small part of this nuclear
compartment. Small isolated eGFP-dots corresponding to indivi-
dual capsids could be found sparsely within, as well as outside, the
RC, albeit the vast majority of the eGFP larger spots were located at
the periphery of the RC.
The major capsid protein (ORF40) appeared in the nuclear struc-
tures at 12 h p.i. and started to strongly accumulate at 16 h p.i (Fig. 3,
white arrows), whereas the presence of ORF33/33.5 corresponding to
the viral procapsid scaffold was more delayed and was only substan-
tially visible at late time points (24 and 36 h p.i.) and in only certain
very large structures (Fig. 4A). On the contrary, the DNA terminase
encoded by ORF45/42 never seemed to accumulate in the dense
structures (Fig. 4B). We can conclude from these results that, like the
HSV-1 assemblons, the observed structures ultimately contain impor-
tant proteins implicated in capsid assembly but not those proteins
that are implicated in DNA replication and encapsidation.
We next wondered whether the structures observed by con-
focal microscopy would be distinguishable at the ultrastructural
level and if they were constituted of fully or partially assembled
capsids or of capsid proteins.
The nuclear dense structures are capsid aggregates that grow in size
in the course of the infection
In order to precisely and irrefutably characterize the nature of
the nuclear dense structures observed in confocal microscopy, we
decided to carry out correlative microscopy. MeWo cells were
grown on a glass-bottom dish, infected for 48 h with eGFP-ORF23
VZV, ﬁxed with paraformaldehyde, stained with Hoechst and
analyzed by confocal microscopy. A Z-stack image was recorded
for each infection focus present on the glass coverslip that was
then unglued from the plastic dish via a short contact with
methanol. The cells on the coverslip were ﬁxed again with
glutaraldhehyde and osmium tetroxide, embedded in epon and
processed for transmission electron microscopy (TEM). Ultrathin
sections were carefully examined and compared with confocal
images to clearly assess a concordance. Pictures of the chosen area
were then systematically recorded on all available sections. The
image of an infection focus was reconstructed from ten separate
TEM images (Fig. 5A) and compared with the confocal Z-stack and
(Fig. 5B). As seen on the higher magniﬁcations (Fig. 5C and D),
each intense ﬂuorescent spot, regardless of its size, corresponds, at
the ultrastructural level to an array of capsids, residing at the
periphery of the RC. The latter was easily detectable as a paler area
in the center of the nucleus. We conﬁrmed that the size of the
capsid aggregates increases over the time during the infection
process by analyzing ultrathin sections of MeWo cells infected at
8 h, 12 h, 16 h and 24 h p.i. (data not shown). In order to prove that
the dense ﬂuorescence structures observed in wild-type VZV-
infected cells immunostained for both ORF23 and ORF40
(Fig. S1) truly reﬂect the presence of capsid aggregates in a wild-
type infection, pOka VZV-infected MeWo cells were analyzed by
TEM in parallel of eGFP-ORF23 VZV-infected cells. We indeed
detected similar capsid aggregates with the wild-type virus
(Fig. 6A). We examined the capsid content of two separate nuclear
compartments: the capsid aggregates and the RC. For the latter, we
only kept nuclei for which a well-deﬁned RC was present and to
avoid bias due to small capsid aggregates and tangent sections of
large capsid aggregates, which were present at the periphery of
the RC, we excluded a 0.5 mM strip at the edge of the RC from the
counting. Over 3000 capsids were counted (within 22 nuclei and
43 capsid aggregates of eGFP-ORF23 VZV-infected cells and
12 nuclei and 14 capsid aggregates for the wild-type infection).
We also frequently observed a fourth type of capsid within the
aggregates. These particles comprised an inside ring surrounded
by a thinner and more deﬁned outer edge and corresponded, by
comparison to what is known about HSV-1 (Newcomb et al., 2000;
Thomsen et al., 1995), to VZV procapsids (Fig. 6A). For both viruses,
we found that the mean percentage of each type of capsid within
the aggregates was statistically different from that within the RC.
We noted that the predominant form of capsid found within the
aggregates is the B type, which is also the most abundant
throughout the nucleus. Importantly, capsid aggregates were also
enriched in procapsids, which were even totally absent from the
central part of the RC in a wild-type infection (Fig. 6B).
During this analysis, we noticed that the distribution of C
capsids within the aggregates did not seem random. We then
decided to classify them regarding to their position within the
aggregates. C capsids that were part of the most exterior layer of
capsids were considered as belonging to the periphery. Based on
this criteria, we observed that 86% of C capsids within the
aggregates actually resided at the periphery (Fig. 6C). If we
considered the periphery as the two most external layers of capsid,
this percentage peaked to over 95% (data not shown). Another
very interesting point was the presence of some partial capsids
that were not observed elsewhere in the infected nuclei (Fig. 6D)
and which are thought to be precursors of procapsids.
Some capsid aggregates entrappedwithin PML-cages have recently
been described in VZV-infected cells at late time points (Reichelt et al.,
2011). We therefore wondered whether the observed structures could
represent earlier stages of those aggregates.
VZV nuclear capsid aggregates form independently of the presence
of the PML bodies
We generated a MeWo cell line stably expressing a shRNA
against all PML isoforms via retroviral vectors particles transduc-
tions and from an already described plasmid (pSuper-Retro-
Hygro-shPML, a kind gift from Dr. C. Kyratsous; Kyratsous et al.,
2009). Non-transduced MeWo cells in parallel with sh-PML
expressing cells were infected with eGFP-ORF23 VZV and ﬁxed
24 h p.i. Immunostaining against PML was performed to control
the knockdown of the gene (Fig. 7). Nuclear dense ﬂuorescent
structures were present in both cell lines showing that the PML
bodies are not required for their formation. TEM analysis of eGFP-
ORF23 infected-sh-PML MeWo cells revealed the presence of
capsid aggregates similar to those observed in non-transduced
MeWo cells (data not shown). This suggests that they may
represent a virus-induced nuclear compartment that is important
for its life cycle rather than a cellular defense that progressively
entraps newly formed capsids, impeding their egress. This
prompted us to characterize the dynamics of the formation of
these structures.
Capsid aggregates are dynamic rather than static structures
We infected MRC5 cells via cell contact with eGFP-ORF23 VZV-
infected MeWo cells for 12 h and then took pictures every 2 s over
a 15 min time frame (Movie S3). Most of the capsids were in
constant movement but a few static ﬂuorescent dots could also be
observed. During the 15 min time frame, some of those static dots
developed into nascent aggregates whose size constantly evolved
whilst seemingly preserving their initial nuclear location (supple-
mental Movie S3, white arrow). Isolated capsids seemed to
constantly move from and towards the aggregates. We next
studied the dynamics inside the aggregates via a Fluorescence
Recovery After Photobleaching (FRAP) experiment. Infected MRC5
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were analyzed 16 h p.i. in order to obtain aggregates of moderate
size. We bleached a region of interest (ROI) corresponding to half
of the aggregate during 45 s (Fig. 8 A and supplemental Movie S4)
and then took pictures every 15 s. After 2 min post-bleaching, the
ﬂuorescence already started to reappear in the bleached area, but
it took 10–15 min to return to the original situation where the
ﬂuorescence was homogenous overall the entire structure. This
speed of ﬂuorescence recovery was not compatible with a fast
protein diffusion, like that observed if we bleached a ROI of
diffused eGFP in the cytoplasm corresponding to the signal of
the fusion protein rather than fully assembled capsid (data not
shown). On the contrary, it could be compatible with a movement
of capsids within the aggregates, which is expected to be much
slower. As there appeared to be a permanent exchange between
the capsids residing inside and outside the aggregate (supple-
mental Movie S3), we performed a Fluorescence Loss In Photo-
bleaching (FLIP) experiment and showed that if the structure was
bleached constantly for a certain time, an entire area of the
nucleus was bleached (Fig. 8B and supplemental Movie S5). One
should note that around 16 h p.i., the RC was very frequently still
divided into several areas separated by a thin layer of cellular
genomic DNA and each of these replication sub-compartments
contained one to three capsid aggregates. Interestingly, supple-
mental Movie S6 suggested that the capsid aggregates could
sometimes give rise to a massive simultaneous transfer of a large
amount of capsids from the nucleus to the cytoplasm (see white
arrows). Further experiments would be required in order to
evaluate the importance of this phenomenon for the VZV lytic
cycle and to determine whether this massive transfer occurs via a
budding through the inner nuclear membrane or via a transient
enlargement of the nuclear pores.
As we hypothesized that not only capsid assembly but also
maturation can occur in the described structures, we wondered
whether a partial tegumentation could take place there.
The tegument proteins ORF21 and ORF22 but not ORF9 co-localize
with the capsid aggregates
Until very recently (Lenac Rovis et al., 2013), antibodies against
VZV proteins, in particular against structural proteins, were quite
Fig. 5. The nuclear dense structures are capsid aggregates. MeWo cells were infected for 48 h with eGFP-ORF23 VZV in a glass-bottom dish. Cells were ﬁxed, labeled with
Hoechst and analyzed by confocal microscopy. A Z-stack of pictures was recorded for each infection focus. The glass coverslip was then separated from the plastic dish and
the cell monolayer was re-ﬁxed and embedded in Epon for analysis by Transmission Electron Microscopy. Several pictures obtained by TEM (A) were merged to reconstitute
one of the infection focus identiﬁed by confocal microscopy (B); dotted line frames delineate areas chosen for the panels C and D. (C) and (D) Higher magniﬁcation of ﬁeld
portions: Ag, capsid aggregates (numbered to make the correspondence between TEM and confocal images); nuc, nucleolus; RC, replication compartment.
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Fig. 6. Nuclear capsid aggregates present a characteristic organization and contain many procapsids. MeWo cells infected with eGFP-ORF23 or pOka VZV were analyzed by
TEM. The proportion of the four types of capsids (procapsids, A, B and C, black arrows) present within the aggregates and the replication compartment was determined by
systematic counting of randomly chosen infected nuclei. Representative pictures are shown in (A) and mean percentages in (B); error bars represent the standard deviation.
Mean percentages were pairwise compared using a two-tailed t-test in order to determine statistically signiﬁcant differences; p values are presented in the table under the
graph, NS, non-signiﬁcant. (C) The C capsids present within the aggregates were divided into two categories on the basis of their localization; periphery was strictly
determined as the most exterior layer of capsids and mean percentage are shown, with error bars representing the standard deviation. (D) Late partial capsids can be found
in the nuclear capsid aggregates of both viruses (black arrows).
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sparse and were not always suitable for immunostaining. In order
to identify potential tegument proteins residing in the structures,
dually ﬂuorescent VZV were created, starting from our eGFP-
ORF23 BAC construct. Three different proteins were chosen:
ORF21 and ORF22, homologous to HSV-1 UL37 and UL36, respec-
tively, which are supposed to belong to the inner tegument, and
ORF9, corresponding to HSV-1 VP22. As we had already deter-
mined from the targeting of ORF23 that the orientation of the
ﬂuorescent tag regarding the gene could be of a great importance,
we directly tested both possibilities. Moreover, in order to max-
imize our chances of obtaining viable viruses with the brightest
fusion protein, two different red ﬂuorescent tags were used:
DsRed-monomer (referred to as “mDsRed”) and tagRFP-T (referred
to as “tRFP-T”). Only three of the 12 different BACs that were
created gave rise to highly infectious VZV after transfection into
MeWo cells (Fig. 9A). Other constructs either totally failed to lead
to infection foci, even four weeks after transfection, or engendered
very slowly replicating viruses (data not shown). The addition of a
second ﬂuorescent tag did not seem to further impact the
replication kinetics of the virus (Fig. 9B). The distribution of the
red ﬂuorescence in infected living MeWo cells (Fig. 9C) 24 h p.i.
revealed that the three proteins were present mostly in the
cytoplasm, but also in some discrete nuclear locations. ORF21
and ORF22 were present in some of the capsid aggregates (Fig. 9C,
white arrows), although, most of the time, only a portion of the
eGFP-ORF23 area was also positive for either mDsRed-ORF21 or
mDsRed-ORF22 (Fig. 9C, insets). On the contrary, ORF9, which was
mostly displayed as cytoplasmic aggregates, was never detected in
these nuclear structures.
Discussion
The entire process of VZV virion formation and egress is far
from being fully elucidated. Nucleocapsid formation in the infected
cells leads to dramatic changes in the nuclear architecture, the role
of which is not entirely understood.
In order to better understand these processes, we created a
virus with the small capsid protein ORF23 fused to the eGFP. With
this virus, we identiﬁed nuclear ﬂuorescent dense structures
emerging around 8–12 h p.i. and enlarging whilst the infection
progressed. As revealed by confocal microscopy, the identiﬁed
structures contain capsid and procapsid proteins as well as some
proteins that supposedly belong to the inner tegument. This
prompted us to question whether they were similar to the already
described HSV-1 assemblons. These structures were ﬁrst identiﬁed
in optical microscopy with antibodies against capsid proteins, but
the fusion of HSV-1 VP26 with different ﬂuorescent tags has
Fig. 7. The nuclear dense structures corresponding to capsid aggregates also appear in PML-depleted cells. shPML-MeWo cells as well as non-transduced MeWo cells were
infected with eGFP-ORF23 VZV for 24 h and analyzed by immunoﬂuorescence using an anti-PML antibody (Alexa568 secondary antibody). Confocal microscope images were
captured with a 63 oil-objective.
Movie S3. Nuclear capsid aggregates are dynamic structures that seem to originate
at speciﬁc locations. MRC5 were infected via cell contact with eGFP-ORF23 MeWo
cells. 12h post infection, pictures were recorded every 2 s for a 15 min period.
Confocal microscope images were captured with a 60 oil-objective. White arrow
points to the nascent aggregate. A video clip is available online. Supplementary
material related to this article can be found online at doi:10.1016/j.virol.2014.02.
023.
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demonstrated that this protein forms peculiar aggregates whose
size increases during the course of the infection and likely
correspond to the assemblons (de Oliveira et al., 2008; Desai and
Person, 1998). Remarkably, the C-terminal region of VP26 contain-
ing stretches of conserved residues has been demonstrated
to carry an interaction motif with the capsids and to redirect
VP26 to nuclear spots deﬁned as assembly sites (Desai et al., 2003).
Nevertheless, attempts to relate those intense ﬂuorescent spots
with some virus-induced structures, discernible on ultrathin sec-
tions of infected cells, have remained quite scarce (Feierbach et al.,
2006; Nagel et al., 2012). A recent publication has even shown that
the fusion of HSV-1 VP26 with some ﬂuorescent tags can lead to
Fig. 8. Nuclear capsid aggregates are dynamic structures. MRC5 cells were infected for 16 h with eGFP-ORF23 VZV via cell contact followed by extensive washing. (A) A
region of interest (ROI) represented by the white circle was bleached for 45 s and then an image was recorded every 15 s for 15 min. Selected time points are shown. (B) A ROI
represented by the red shape was ﬁrst bleached for 1 min before successive steps of bleaching and image acquisition. Selected time points are shown. Confocal microscope
images were captured with a 60 oil-objective equipped with a chamber controlling the temperature and the CO2 level.
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the formation of fusion protein aggregates impeding viral growth
(Nagel et al., 2012). Here, in VZV-infected MeWo cells, we show
indisputably, via correlative microscopy, that the nuclear
structures observed in confocal microscopy actually correspond
to capsid aggregates identiﬁed in electron microscopy. We com-
pared our eGFP-ORF23 VZV with a wild-type virus, and observed
similar nuclear dense structures in confocal microscopy corre-
sponding to similar capsid aggregates found in TEM. This proves
that the structures described here were not artefactually induced
by the eGFP-ORF23 fusion protein. Even though we cannot
exclude the possibility that VZV behaves differently from the other
alphaherpesviruses, we believe that it might be very important to
reevaluate some HSV-1 and PRV data, in light of the current study.
The major question to be asked concerns the potential func-
tionality of these nuclear structures. The presence of numerous A,
B and C capsids, as well as many procapsids, suggests that they
may indeed represent sites where assembly can take place.
Procapsids are usually rarely seen in the nucleus of infected cells,
due to their rapid maturation into A, B and C capsids (Newcomb
et al., 1996; Trus et al., 1996). The high percentage of procapsids
within the aggregates, and the identiﬁcation, only in this nuclear
compartment, of partial procapsids, representing earlier stages of
assembly (Newcomb et al., 1999), are strong arguments in favor of
a functional role of these structures. Of course, these sites are
highly unlikely to be the sole location of capsid formation, since
some infected nuclei are devoid of them and the ﬁrst newly
formed capsids appear randomly distributed within the RC. Of
note, while procapsids are completely absent from the RC in a
wild-type infection, a signiﬁcant amount of them can be found in
the RC of cells infected with the eGFP-ORF23 VZV. Moreover, the
proportion of procapsids within the aggregates is signiﬁcantly
higher for the eGFP-ORF23 compared to the wild-type virus (26.6%
vs. 14.9%). We believe that this may reﬂect a slower maturation
rate, probably due to the presence of the eGFP tag, and this could,
in part, explain the growth defect of the recombinant virus
compared to the wild-type. The presence of the tag could, for
example, impact the assembly of the portal complex or the
expulsion of the scaffold. This could explain the negative dominant
effect observed with some ﬂuorescent protein-VP26 fusion com-
binations, which were described for HSV-1(Nagel et al., 2012) and
that we actually observed in an attempt to fuse ORF23 to mCFP
and mYFP (data not shown). If true, the fact that we observed a
few procapsids within the RC of eGFP-ORF23 VZV-infected nuclei
suggest that, indeed, a few number of capsids are produced in this
nuclear compartment but that the procapsids are very rapidly
converted in ulterior maturation stages, rendering their visualiza-
tion quite difﬁcult in a wild-type infection.
Another interesting point is that the capsids within the
aggregates are not organized randomly. C-capsids are almost
always found at their periphery, and, also, the proportion of the
different types of capsids does not mirror that found in the rest of
the nucleus. If the aggregates were simply due to an excess of
capsids at late time points of infection, these observations would
not be expected. It is tempting to speculate that DNA encapsida-
tion occurs at the periphery of the aggregates, but our data cannot
exclude the possibility that some C capsids produced in the RC
could later be sequestered at the periphery of these aggregates.
The presence of numerous B capsids, which are largely thought
to be dead end particles, in the aggregates surely provides an
argument for a depot of mostly immature capsids with no function
in the viral life cycle. It would be very interesting to measure the
proportion of the different types of capsid within the aggregates
over time to evaluate whether their increasing size is mainly
attributable to an increasing number of B capsids.
Some VZV capsid aggregates entrapped in PML-cages have
recently been identiﬁed in the nucleus of infected cells (Reichelt
et al., 2012; Reichelt et al., 2011), which is believed to limit capsid
egress to the cytoplasm. We ﬁrst thought that the structures
described here represented earlier stages of this phenomenon.
Movie S4. FRAP experiment showing that capsids within the nuclear aggregates
are not static. MRC5 were infected via cell contact with eGFP-ORF23 MeWo cells.
16h post infection, a region of interest represented by the white circle, was
bleached for 45 s and then an image was recorded every 15 s for 15 min. Confocal
microscope images were captured with a 60 oil-objective. A video clip is
available online. Supplementary material related to this article can be found online
at doi:10.1016/j.virol.2014.02.023.
Movie S5. FLIP experiment showing that capsids are constantly moving from and
towards the nuclear aggregates. MRC5 were infected via cell contact with eGFP-
ORF23 MeWo cells. 16h post infection, a region of interest represented by the red
shape, was ﬁrst bleached for 1 min before successive steps of bleaching and image
acquisition. A video clip is available online. Supplementary material related to this
article can be found online at doi:10.1016/j.virol.2014.02.023.
Movie S6. Entire capsid aggregates seem to be able to be transferred into the
cytoplasm in one step. HFF were infected via cell contact with eGFP-ORF23 MeWo
cells. 16h post infection, pictures were recorded every 15 min over a 13 h time frame.
White arrows show two successive bursts of capsid aggregates within the cytoplasm.
A video clip is available online. Supplementary material related to this article can be
found online at doi:10.1016/j.virol.2014.02.023.
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However, when we silenced PML gene expression via shRNA
technology, we still observed eGFP-ORF23 intense ﬂuorescent
spots in confocal microscopy, as well as capsid aggregates in
TEM (data not shown). Moreover, we demonstrated, by FRAP and
FLIP technology, that there is a constant movement of capsids
within the structures as well as a permanent exchange between
the capsids residing in the structures and the capsids present
elsewhere in the replication sub-compartments. Of note, an
interesting study on PRV showed that the formation of capsid
assembly sites within the nucleus is a dynamic process requiring a
Fig. 9. ORF21 and ORF22 tegument proteins co-localize with nuclear capsid aggregates whereas ORF9 does not. (A) Schematic representation of the genomic region that has
been modiﬁed in the BAC-VZV eGFP-ORF23 to create the dually ﬂuorescent viruses. (B) Growth curve of the dually ﬂuorescent viruses compared to the eGFP-ORF23. The
same technique was used as described in Fig. 1A, except that 500 infected cells were used instead of 200. Means of a representative experiment out of three are depicted;
error bars represent the standard deviation. (C) Live visualization of MeWo cells infected for 24 h with eGFP-ORF23/mDsRed-ORF21, eGFP-OR23/mDsRed-ORF22 or eGFP-
ORF23/ORF9-tRFP-T. Nuclei were labeled with Hoechst and confocal microscope images were captured with a 63 oil-objective. White arrows in insets point to co-
localization between eGFP-ORF23p and mDsRed-ORF21 or mDsRed-ORF22; solid grey lines delineate nuclei from the Hoechst labeling.
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virally induced “nucleo-squeleton” (Feierbach et al., 2006). We
cannot exclude the possibility that the dynamic nature and the
growing size of the aggregates could also reﬂect an inability of the
capsids to efﬁciently egress the nucleus towards the cytoplasm. In
that case, aggregates could then be locations where capsids simply
accumulate, maybe in order to gain some of the properties that are
necessary for the future egress or simply waiting for some
processes to be achieved, like the disruption of the nuclear lamina
or the maturation of the RC, subsequently giving the capsids access
to the inner nuclear membrane through which they need to bud.
The ultimate demonstration that the structures identiﬁed here
have a crucial role for the virus life cycle would require a system in
which we can impede their formation and show that it impacts
capsid formation or egress, which is, unfortunately, difﬁcult to set
up. Nevertheless, attempts to prove that the nuclear punctuated
patterning of VP26 is essential for viral replication have recently
been carried out on EBV and KSHV with capsid self-assembly
systems. Indeed, VP26 nuclear distribution has been shown to be
dependent on its interaction with the major capsid protein and the
deletion of the region that is essential for its peculiar localization
in the nucleus impedes capsid formation (Henson et al., 2009;
Perkins et al., 2008).
In this study, we created the three ﬁrst dually ﬂuorescent VZV
where, not only ORF23, but also an additional tegument protein
was ﬂuorescently labeled.
With these viruses, we showed that ORF9 is mainly displayed as
cytoplasmic aggregates that could be related to its role in secondary
envelopment which we recently demonstrated (Riva et al., 2013). The
localization of ORF21 and ORF22, belonging to the inner tegument, in
the nuclear capsid aggregates revives the debate surrounding where
the initial step of tegumentation takes place. The presence of UL36
(ORF22 homolog) in the nucleus of PRV and HSV-1-infected cells is
highly controversial. Some reports demonstrating its presence in the
nuclear compartment (McNabb and Courtney, 1992), at the nuclear
envelope (Morrison et al., 1998) and its associationwith intranuclear C
capsids (Bucks et al., 2007) are corroborated by the presence in its
N-terminal region of a recently described functional and highly
conserved, Nuclear Localization Signal (Abaitua and O'Hare, 2008).
Moreover, another highly conserved 62 bp sequence, in the C-terminal
region of PRV UL36, has been shown to be essential for viral
replication and to be able to redirect the GFP to nuclear assemblons
upon infection (Lee et al., 2006). This region has since been shown to
be functionally conserved in HSV-1 (Coller et al., 2007). On the other
hand, some groups failed to detect any UL36 in the nuclear compart-
ment or in association with nuclear capsids, either on ultrathin
sections or after extraction on sedimentation gradients (Klupp et al.,
2002; Mohl et al., 2009; Trus et al., 2007). The amount of ORF22 found
in VZV-infected nuclei is very low compared to the cytoplasmic level
and the use of a virus expressing ﬂuorescently tagged ORF22
circumvents issues linked to antibodies' sensitivity and the possible
masking of epitopes, potentially through protein conformation or
post-translational modiﬁcations. This might, in part, explain the
discrepancies between some published data and those reported here,
bearing in mind that the VZV ORF22 localization has never been
speciﬁcally investigated before. ORF21 has already been shown in the
nucleus of VZV-infected cells, but not in association with peculiar
structures (Cohrs et al., 2002). It is very interesting to note that the
previously described UL37-GFP/VP26-mRFP-expressing HSV-1 dis-
plays a high degree of co-localization of capsids with UL37 at the
Trans-Golgi Network, but also at some particular nuclear sites that
strongly resemble the structures that we observed (Desai et al., 2008).
The localization of both ORF22 and ORF21 at the nuclear capsid
aggregates is also corroborated by a very recent report demonstrating
that up to 5 tegument proteins could be added to the HSV-1 particle
at the nuclear stage, among which were UL36 and UL37 (Henaff et al.,
2013). In order to conﬁrm that the addition of a ﬂuorescent tag on
both proteins does not alter their localization, we puriﬁed VZV virions
via two successive gradient steps (sucrose, then potassium tartrate-
glycerol) (Kinchington et al., 1995), and, via western-blotting with an
antibody against dsRed, conﬁrmed the presence of DsRed-ORF21 in
the viral particles (data not shown). However, we were unable to
detect the presence of DsRed-ORF22, neither on the infected cell
extracts, nor with highly puriﬁed virions extracts (data not shown).
A recent Yeast-Two-Hybrid screen has identiﬁed ORF21 as an
interacting partner of both ORF23 and ORF22 (Stellberger et al.,
2010) and HSV-1 and PRV UL36 and UL37 are also well known to
interact (Kelly et al., 2012; Klupp et al., 2002; Lee et al., 2008).
These interactions could explain the presence of the two tegument
proteins in the observed structures.
Of interest, while both UL36 and UL37 of PRV and HSV-1 have
been shown to play a role in the viral particle maturation at the
cytoplasmic step, PRV UL36 and HSV-1 UL37 speciﬁcally have also
been shown to be crucial for the nuclear egress (Desai et al., 2001;
Desai, 2000; Klupp et al., 2001; Luxton et al., 2006). It is therefore
possible that a layer of tegument is necessary for the capsid to bud
through the inner nuclear membrane.
To date, we do not know why the co-localization of those two
tegument proteins is not homogenous within the capsid aggre-
gates and only arise in some of them, but, as revealed by TEM, the
capsid content seemed to evolve during the infection process; it is
therefore possible that the protein composition is not homogenous
between aggregates. Now that a new bank of antibodies against
VZV proteins has been generated (Lenac Rovis et al., 2013),
it would, of course, be very interesting to deﬁne the protein
composition along with capsid type proportions of the structures
over time in more detail by using both TEM and confocal
microscopy.
Altogether, our data show that VZV induces the formation of
nuclear structures containing capsid and tegument proteins, as
well as assembled A, B and C capsids and procapsids. These
dynamic capsid piles start to appear at speciﬁc and deﬁned
locations within the nucleus as early as 8–12 h post-infection
and are located at the periphery of the replication compartment.
We believe that those structures could be implicated in capsid
assembly and/or maturation before egress towards the cytoplasm.
The presence of two inner tegument proteins suggests that a ﬁrst
step of tegumentation might take place in this nuclear sub-
compartment.
Materials and methods
Construction of the BAC-VZVΔGFP
The GFP cassette was removed from the BAC-VZV (kindly
provided by Dr. Zhu) and replaced by an ampicillin resistance
gene, ampliﬁed by PCR with the primers listed in Table S1, via
homologous recombination with the E. coli strain DY380 according
to the recombineering protocol #1 of Dr. Warming at NCI-
Frederick. Recombinants were analyzed by PCR and sequencing
(Table S2).
Construction of recombinant viruses
Viruses presenting one (or two) open reading frame(s) fused
with ﬂuorescent protein encoding genes were constructed by
modifying the BAC-VZV-ΔGFP. They were created by bacterial
recombineering using the GalK positive/negative selection techni-
que described by Warming et al. (2005) and materials(plasmid
pGalK and bacterial strain SW102) were obtained from the Biology
Research Branch (BRB) at the NCI, Bethesda, MD. Recombination
cassettes were PCR ampliﬁed with the speciﬁc primers and
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templates (Table S1). Recombinants were screened by PCR using
the primers listed in Table S2. The constructions were veriﬁed by
restriction digestion pattern and DNA sequencing.
Cell culture
Human melanoma cell line (MeWo) (ATCC number HTB-65)
and human primary embryonic lung ﬁbroblasts (MRC5) were
cultured in Eagle's minimal essential medium supplemented with
1% of non-essential amino acids, 1% glutamine, 1% antibiotic mix
(penicillin–streptomycin) and 10% FBS (Fisher Scientiﬁcs, GIBCO).
Primary Human Foreskin Fibroblasts (HFF) were cultured in
Dulbecco's modiﬁed Eagle's medium supplemented with 1% glu-
tamine, 1% antibiotic mix (penicillin–streptomycin) and 10% FBS
(Fisher Scientiﬁcs, GIBCO). Human normal keratinocytes immorta-
lized by permanent TERT expression (N/TERT-1 cells) were
obtained from Dr. James Rheinwald (Harvard Skin Disease
Research Center) and cultured according to their protocol (avail-
able upon request at their cell culture facility).
Recombinant virus culture
To reconstitute recombinant viruses, 3 mg of the modiﬁed BACs
per well of 6-well plates were transfected into MeWo cells using
6 ml of JetPEI (PolyPlus transfection), according to the manufac-
turer's protocol. Three days later, the cells were transferred into a
25 cm2 ﬂask and passaged near conﬂuence every 2–3 days until
typical infection foci appeared.
To infect HFF/MRC5/N/TERT-1 cells, strongly infected MeWo
cells were trypsinized and placed in contact with the cells for
20 min. The cells were then washed 3 times with PBS and placed
back in the incubator with complete culture medium.
Determination of viral growth
In order to determine the growth kinetics of the different viral
recombinant strains, infected MeWo cells were trypsinized on day
0 and the proportion of GFP positive cells, corresponding to
infected cells, was determined by FACS (BD CantoII). Four 25 cm2
ﬂasks of MeWo cells for each viral strain were then infected via co-
culture with 200 or 500 infected cells (see ﬁgure legend). On day
1–4, one 25 cm2 ﬂask for each virus was trypsinized and serially
diluted (dilution range from 1/36 to 1/1024, performed in tripli-
cates) on 24-well plates containing uninfected MeWo cells. Three
days post-seeding, the number of infection foci was recorded in
every countable well with an inverted ﬂuorescence microscope. A
second measure was carried out on the following day in order to
increase accuracy.
Western blotting
Protein samples were incubated with sodium dodecyl sulfate
(SDS)-loading buffer (125 mM Tris–HCl [pH 6.8], 4% SDS, 20%
glycerol, 6% β-mercaptoethanol, 0.03% bromophenol blue) and
boiled for 3 min. Proteins were then separated by SDS-PAGE and
transferred onto a polyvinylidene diﬂuoride membrane. Mem-
branes were blocked with 5% nonfat dry milk PBS-Tween and then
incubated with anti-GFP antibody (Roche, 1/500). After 3 washes,
the membrane was incubated with the appropriate secondary
antibody and the proteins of interest were detected using the
Amersham ECL western blotting detection reagents kit (GE Health-
care) and the ImageQuant LAS4000 (GE Healthcare).
Immunoﬂuorescence
Coverslips were washed with PBS, ﬁxed for 30 min in 4%
paraformaldehyde-PBS, permeabilized in 0.1% Triton X100-PBS
and blocked with 10% FBS-PBS. Coverslips were then incubated
for 1–2 h with the primary antibody diluted in 10% FBS-PBS as
follows: mouse anti-beta-tubulin (1/500, Sigma), rabbit anti-PML
(1/50, Santa Cruz), mouse anti-ORF40 (1/50, Santa Cruz), rabbit
anti-ORF29 (1/200, kind gift from Dr. R. Cohrs), rabbit anti-ORF45/
42 (1/200, kind gift from Dr. R. Visalli) or rabbit anti-ORF33/33.5
(1/50, kind gift from Dr. F. Rixon), rabbit anti-ORF23 (1/200, kind
gift from Dr. M. Sommer). After 3 washes in 5% FBS-PBS, coverslips
were incubated for 1 h with the appropriate secondary antibody
(coupled to Alexa568 or Alexa633, as described in the ﬁgure
legend) (Invitrogen) diluted 1/400 in 10% FBS-PBS. After washing
and nuclei staining with Hoechst33342 (Acros Organics) diluted 1/
100,000, coverslips were mounted on glass slides with mowiol.
Images were recorded with an Olympus FV1000 confocal inverted
microscope using a 63 oil objective.
Live imaging
A Nikon A1R confocal microscope equipped with a motorized
platform and a chamber controlling the temperature, the humidity
and the CO2 level was used for all live imaging experiments. For
Fluorescence Recovery After Photobleaching (FRAP) experiments, a
region of interest (ROI) was bleached via 488-laser illumination for
45 s at the laser maximum intensity before recording images every
15 s. For Fluorescence Loss in Photobleaching (FLIP), the ROI was
ﬁrst bleached for 1 min before successive pictures acquisition
(2 frames each time) followed by 5-seconds photobleaching.
Generation of shPML-MeWo cell line
Retrovirus vectors allowing shPML expression were generated
after the transfection of phoenix-Ampho cells (ATCC #SD3443)
with the pCKsuper-shPML (kind gift from Dr. C. Kyratsous). The
retrovirus vectors were used to transduce MeWo cells that were
selected with ﬁrst 200 and then 500 mg/ml of hygromycin.
Electron microscopy
VZV eGFP-23p-infected wild-type MeWo cells and shPML-
MeWo cells were washed in Sörensen's buffer and ﬁxed for 1.5 h
at 4 1C with 2.5% glutaraldehyde in a Sörensen 0.1 M phosphate
buffer (pH 7.4) and post-ﬁxed for 30 min with 2% osmium
tetroxide. After dehydration in graded ethanol, samples were
embedded in Epon. Ultrathin sections obtained with a Reichert
Ultracut S ultramicrotome were contrasted with uranyl acetate
and lead citrate. Observations were made with a Jeol JEM-1400
transmission electron microscope at 80 kV.
Correlative microscopy
MeWo cells grown in a 35 mm glass-bottom dish were infected
via cell contact for 48 h with eGFP-ORF23 VZV, washed with PBS
and ﬁxed with 4% paraformaldehyde-PBS. In order to reduce the
surface of cells to be analyzed, most of the monolayer was scraped
off the dish to leave a central small area which was stained with
Hoechst (1/100 000 for 5 min), washed 3 times with PBS and
visualized by confocal microscopy. An image Z-stack was recorded
for each infection focus present on the glass coverslip that was
then unglued from the plastic dish via a 10 s contact with
methanol. The cells on the coverslip were ﬁxed again for 1 h at
room temperature with 2.5% glutaraldehyde in a Sörensen 0.1 M
phosphate buffer (pH 7.4) and post-ﬁxed for 30 min with 2%
M. Lebrun et al. / Virology 454-455 (2014) 311–327 325
osmium tetroxide. After dehydration in graded ethanol, samples
were embedded in Epon. Serial ultrathin sections obtained with a
Reichert Ultracut S ultramicrotome were contrasted and observed
as described above. Ultrathin sections were carefully scrutinized
and compared with confocal images until a concordance was
clearly assessed. Pictures of the chosen area were then system-
atically recorded on all available sections.
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